Home » Topics » BioWorld Science

BioWorld Science
RSS

Hemispherian closes seed funding to advance preclinical pipeline for cancer

May 3, 2022

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

May 3, 2022

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

May 3, 2022

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

May 3, 2022

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

May 3, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

May 3, 2022

Storm Therapeutics identifies new METTL3 inhibitors

May 3, 2022

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

May 3, 2022

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

May 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...